Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer

M D Franken, Ellen Rooijen, AM May, H Koffijberg, H van Tinteren, L Mol, AJ ten Tije, GJ Creemers, AMT van der Velden, BC Tanis, CAU-d Groot, CJA Punt, M Koopman, MGH van Oijen

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)204-212
Number of pages9
JournalEuropean Journal of Cancer
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this